Regeneron Announces Upcoming 2015 Investor Conference Presentations
TARRYTOWN, N.Y., April 29, 2015 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences:
- Bank of America Merrill Lynch 2015 Healthcare Conference at 11:20 a.m. Pacific Time (2:20 p.m. Eastern Time) on Tuesday, May 12, 2015
- Barclays 2015 Biotech CEO/CFO Conference Call Series at 11:00 a.m. Eastern Time on Thursday, May 14, 2015
- Sanford C. Bernstein’s 31st Annual Strategic Decisions Conference at 4:00 p.m. Eastern Time on Wednesday, May 27, 2015
The sessions may be accessed through the Company’s web site, www.regeneron.com, on the ‘Events and Presentations’ page. Archived versions of the presentations will be available for 30 days.
About Regeneron Pharmaceuticals, Inc.
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis. For additional information about the company, please visit www.regeneron.com.